Here's a realistic clinical picture: semaglutide and tirzepatide have substantial clinical evidence as prescription weight-management tools for eligible patients when prescribed and monitored by qualified healthcare professionals
Journal of Strength and Conditioning Research, 20 (2), 284-291
52 : 297303 Arduini A, Rossi M, Mancinelli G, Belfiglio M, Scurti R, Radatti G et al
Panuszko, A., Szymczak, M., Duewska, J., Godlewska, J., Kuffel, A., & Brudziak, P
Those with conditions like IBS, IBD, gastritis, or ulcers often use oral protocols with doses of 0.5 to 1 mg daily to maximize local gastrointestinal exposure
It's nice to have choices as a provider org